v3.26.3
Management and Director Compensation (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Aug. 07, 2026
Aug. 31, 2026
Apr. 30, 2026
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]              
Officers compensation       $ 433,460 $ 788,322 $ 1,420,801 $ 2,316,641
Directors cash compensation       100,000 100,000 300,000 300,000
Director [Member]              
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]              
Shares issued     500        
Common stock value   $ 71,709 $ 96,900        
Shares issued 2,915            
All Directors [Member]              
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]              
Directors cash compensation       $ 100,000 $ 100,000 300,000 $ 300,000
Advanomics Corporation [Member]              
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]              
Officers compensation           $ 472,000